Nanobodies
Therapeutic Nanobodies and Intrabodies Rewriting the Rules of Target Engagement
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-10May 27, 2025
Pandemic
Global Health at a Crossroads and the Future of Pandemic Preparedness
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-17Mar 12, 2025
CRO
Lindus Health Rolls Out "All-in-One Infectious Disease CRO" Bespoke to Clinical Trials for Infectious Disease Interventions
Lindus Health
PR-11-24-NI-113Nov 19, 2024
Vaccines
Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines
David Dodd; Mark Newman, Ph.D.
GeoVax Inc.
PAO-10-23-CL-07Nov 09, 2023
Immunotherapy
Applying the Principles of Immunotherapy to Infectious Diseases
Jeffrey Stein, Ph.D.
Cidara Therapeutics
PAP-Q2-20-CL-018Jul 01, 2020
Immunotherapy
Using a Natural Molecular Warning System to Fight Cancer and Infectious Diseases
Jeff Wolf
Heat Biologics
PAP-Q2-20-CL-020Jul 01, 2020
Investment
The Pfizer Foundation Invests in 20 Organizations Tackling Infectious Diseases and Antimicrobial Resistance
The Pfizer Foundation
PR-M08-19-NI-072Aug 26, 2019
Opioid Abuse
Opioid Abuse is Linked to a Rise in Infectious Diseases
Emilie Branch
Pharma's Almanac
PAO-M07-19-NI-016Jul 10, 2019
Announcement
AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead in Infectious Disease
AbCellera Biologics Inc.
PR-M06-19-NI-017Jun 14, 2019
Antibiotics
Infectious Diseases Experts Convene to Explore Lifesaving Antibiotic Research Methods
Nice Insight
PR-M11-18-NI-052Nov 15, 2018
Clinical Research
CRO Pharmaceutical Product Development Wins NIH Contract for HIV Research
Nice Insight
PAO-M11-17-NI-021Nov 14, 2017
Partnership
New Partnership to Tackle Challenging Infectious Diseases
Emilie Branch
Pharma's Almanac
PAO-M07-17-NI-005Jul 07, 2017